Co-Authors
This is a "connection" page, showing publications co-authored by Robert Flisiak and Dorota Kozielewicz.
Connection Strength
2.074
-
Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study. J Inflamm Res. 2021; 14:3359-3366.
Score: 0.239
-
Impact of Kidney Failure on the Severity of COVID-19. J Clin Med. 2021 May 10; 10(9).
Score: 0.236
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021. Pol Arch Intern Med. 2021 05 25; 131(5):487-496.
Score: 0.236
-
Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6. J Clin Med. 2021 Apr 09; 10(8).
Score: 0.235
-
Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study. Pol Arch Intern Med. 2021 01 29; 131(1):103-110.
Score: 0.230
-
Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study. J Clin Med. 2020 Dec 24; 10(1).
Score: 0.230
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020. Pol Arch Intern Med. 2020 10 29; 130(10):915-918.
Score: 0.228
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 1 as of June 8, 2020. Pol Arch Intern Med. 2020 06 25; 130(6):557-558.
Score: 0.222
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020. Pol Arch Intern Med. 2020 04 30; 130(4):352-357.
Score: 0.219